Tenaya Therapeutics | IPO Presentation Deck

Slide schematic 5/5

list 3/3 title 2/2

Components 5

bullet bullet timeline-item action-title headline

Tools 1

Monroe's Motivated Sequence slide · 50%

list/bullet: US PTO Notice of Allowance supporting TN-201 IP; No unexpected safety signals; Manufacturing process locked (at 200L scale); Feedback from multiple regulatory agencies; Orphan Drug Designation; Positive enga

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 1

list-presentation 90%

The slide uses a structured list format to communicate progress and milestones.

Find anything

The slide uses a two-column layout to contrast past achievements (Progress) with future goals (Next Steps).